Results 151 to 160 of about 11,700 (225)

Preservative-free versus preserved latanoprost eye drops for reducing intraocular pressure: a non-inferiority phase III randomized, multi-center, single-blind, parallel-group controlled trial

, 2021
Panos Theodosiadis, Anastasios G. P. Konstas, Ioannis Halkiadakis, Vasiliki Dimera, Dimitrios Koufakis, Constantine D. Georgakopoulos, Evgenia Kanonidou, Ηλίας Ζιντζαράς, Konstantina Soulele, Antonios Margaritis, Lida Kalantzi   +10 more
openalex   +2 more sources

Persistence with topical glaucoma therapy in Japan from the perspective of product, formulation, and patient characteristics: analysis of medical insurance claim data. [PDF]

BMC Ophthalmol
Kabeya K, Satoh H, Yanagi N, Sawada Y.
europepmc   +1 more source

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension. [PDF]

Adv Ther
Konstas AG, Garhöfer G, Lübke J, Voykov B, Ropo A.   +4 more
europepmc   +1 more source

Twenty-four hour efficacy of glaucoma medications [PDF]

, 2015
Katsanos, Andreas, Konstas, Anastasios G. P., Mikropoulos, Dimitrios G., QUARANTA, Luciano, Teus, Miguel A., Tranos, Paris G.   +5 more
core   +1 more source

Pseudophakic cystoid macular oedema: 30 months after latanoprost challenge [PDF]

, 2006
Narendra Dhingra, James P. Morgan
openalex   +1 more source

Severe Microbial Keratitis Secondary to Prostaglandin-Associated Periorbitopathy. [PDF]

Case Rep Ophthalmol Med
McCartney MH, Sammouh FK, Tong JY, Chehade M, Selva D.   +4 more
europepmc   +1 more source

24-hour intraocular pressure and ocular perfusion pressure in glaucoma [PDF]

, 2013
Katsanos A., QUARANTA, Luciano, RIVA, Ivano, Russo A.   +3 more
core   +1 more source

Angina Pectoris Following Latanoprostene Bunod 0.024% Administration: A Case Report. [PDF]

Cureus
Edakkavil Z, Fazlani M, Longi A, Shaikh A, Sundaram R.   +4 more
europepmc   +1 more source

Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents [PDF]

Marco Brugnera, Marta Vicario‐de‐la‐Torre, Miriam Ana González-Cela Casamayor, José Javier López-Cano, Irene Bravo‐Osuna, Fernando Huete‐Toral, María Luisa González Rubio, Gonzalo Carracedo, Irene T. Molina‐Martínez, Vanessa Andrés‐Guerrero, Rocío Herrero‐Vanrell   +10 more
openalex   +1 more source

Five-Year Outcomes of Omidenepag Isopropyl Monotherapy for Untreated Primary Open-Angle Glaucoma. [PDF]

Cureus
Kanamori A, Kanamori N.
europepmc   +1 more source